NO840313L - Fremgangsmaate for fremstilling av aminosubstituerte pyridazinderivater. - Google Patents

Fremgangsmaate for fremstilling av aminosubstituerte pyridazinderivater.

Info

Publication number
NO840313L
NO840313L NO840313A NO840313A NO840313L NO 840313 L NO840313 L NO 840313L NO 840313 A NO840313 A NO 840313A NO 840313 A NO840313 A NO 840313A NO 840313 L NO840313 L NO 840313L
Authority
NO
Norway
Prior art keywords
procedure
pyridazine derivatives
preparing amino
substituted pyridazine
substituted
Prior art date
Application number
NO840313A
Other languages
English (en)
Norwegian (no)
Inventor
Jean-Pierre Chambon
Kathleen Biziere
Camille-Georges Wermuth
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO840313L publication Critical patent/NO840313L/no
Priority to NO912049A priority Critical patent/NO912049D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO840313A 1983-01-27 1984-01-26 Fremgangsmaate for fremstilling av aminosubstituerte pyridazinderivater. NO840313L (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO912049A NO912049D0 (no) 1983-01-27 1991-05-28 Fremgangsmaate for fremstilling av aminosubstituerte pyridazinderivater.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8301234A FR2540113A1 (fr) 1983-01-27 1983-01-27 Acides derives de la pyridazine actifs sur le systeme nerveux central

Publications (1)

Publication Number Publication Date
NO840313L true NO840313L (no) 1984-07-30

Family

ID=9285330

Family Applications (1)

Application Number Title Priority Date Filing Date
NO840313A NO840313L (no) 1983-01-27 1984-01-26 Fremgangsmaate for fremstilling av aminosubstituerte pyridazinderivater.

Country Status (27)

Country Link
US (1) US4721711A (is)
EP (1) EP0117779B1 (is)
JP (1) JPS59141564A (is)
KR (1) KR910000638B1 (is)
AR (1) AR240045A1 (is)
AT (1) ATE48417T1 (is)
AU (2) AU2372984A (is)
CA (1) CA1238637A (is)
DD (1) DD220026A5 (is)
DE (1) DE3480653D1 (is)
DK (1) DK162985C (is)
ES (1) ES529081A0 (is)
FI (1) FI78691C (is)
FR (1) FR2540113A1 (is)
HU (1) HU193890B (is)
IE (1) IE57054B1 (is)
IL (1) IL70756A (is)
MA (1) MA20018A1 (is)
NO (1) NO840313L (is)
NZ (1) NZ206945A (is)
OA (1) OA07644A (is)
PH (1) PH21162A (is)
PL (1) PL142340B1 (is)
PT (1) PT77993B (is)
SG (1) SG93690G (is)
YU (1) YU14284A (is)
ZA (1) ZA84502B (is)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2540113A1 (fr) * 1983-01-27 1984-08-03 Sanofi Sa Acides derives de la pyridazine actifs sur le systeme nerveux central
DE3664772D1 (en) * 1985-01-14 1989-09-07 Boehringer Ingelheim Kg 12-amino pyridazinoû4',5':3,4¨pyrroloû2,1-a¨isoquinolines, process for their preparation and use
US5082939A (en) * 1987-01-08 1992-01-21 I.S.F. Societa Per Azioni Pyridazine derivatives
US5106973A (en) * 1987-11-23 1992-04-21 Janssen Pharmaceutica N.V. Pyridzainamine derivatives
US5631255A (en) * 1989-02-07 1997-05-20 Sanofi Pyridazine derivatives
FR2663326B2 (fr) * 1989-11-17 1992-10-16 Sanofi Sa Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
FR2668151A1 (fr) * 1990-10-23 1992-04-24 Rhone Poulenc Agrochimie Composes a groupe triazolopyridazine leurs preparations et compositions herbicides les contenant.
FR2676444B1 (fr) * 1991-05-16 1995-03-10 Sanofi Elf Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant.
CN1038249C (zh) * 1991-08-28 1998-05-06 罗姆和哈斯公司 含有二氢哒嗪酮及其相关化合物的杀菌组合物
US20100210590A1 (en) * 1995-09-27 2010-08-19 Northwestern University Compositions and treatments for seizure-related disorders
US20030176437A1 (en) * 2001-08-31 2003-09-18 D.M. Watterson Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death
WO2006050389A2 (en) 2004-11-02 2006-05-11 Northwestern University Pyridazine compounds, compositions and methods
WO2006050359A2 (en) * 2004-11-02 2006-05-11 Northwestern University Pyridazine compounds and methods
CA2650711A1 (en) * 2006-04-28 2007-11-08 Northwestern University Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
EP2015751A2 (en) * 2006-04-28 2009-01-21 Northwestern University Salts of pyridazine compounds
WO2007127375A2 (en) * 2006-04-28 2007-11-08 Northwestern University Formulations containing pyridazine compounds for treating neuroinflammatory diseases
BRPI0809498A2 (pt) * 2007-04-02 2014-09-23 Inst Oneworld Health Compostos inibidores de cftr e seus usos
WO2009131958A2 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, compositions and methods comprising triazine derivatives
WO2009131957A2 (en) 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, compositions and methods comprising oxadiazole derivatives
US8236838B2 (en) * 2008-04-21 2012-08-07 Institute For Oneworld Health Compounds, compositions and methods comprising isoxazole derivatives
WO2009131947A2 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, compositions and methods comprising pyridazine derivatives
WO2010033626A1 (en) * 2008-09-19 2010-03-25 Institute For Oneworld Health Compounds, compositions and methods comprising imidazole and triazole derivatives
US20100267706A1 (en) * 2009-04-20 2010-10-21 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Pyridazine Derivatives
US8343976B2 (en) * 2009-04-20 2013-01-01 Institute For Oneworld Health Compounds, compositions and methods comprising pyrazole derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510998B1 (fr) * 1981-08-07 1986-01-10 Sanofi Sa Nouveaux derives amines de la pyridazine, leur procede de preparation et les medicaments, a action desinhibitrice, qui en comportent
FR2510997A1 (fr) * 1981-08-10 1983-02-11 Sanofi Sa Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant
FR2540113A1 (fr) * 1983-01-27 1984-08-03 Sanofi Sa Acides derives de la pyridazine actifs sur le systeme nerveux central
CA1218655A (en) * 1983-01-28 1987-03-03 Kathleen Biziere Process for the preparation of pyridazine derivatives having a psychotropic action

Also Published As

Publication number Publication date
IL70756A0 (en) 1984-04-30
FI840323A (fi) 1984-07-28
KR840007586A (ko) 1984-12-08
HU193890B (en) 1987-12-28
YU14284A (en) 1986-12-31
AU2142188A (en) 1989-03-16
FI78691C (fi) 1989-09-11
NZ206945A (en) 1987-07-31
DK162985C (da) 1992-06-01
EP0117779B1 (fr) 1989-12-06
AR240045A1 (es) 1990-01-31
IE840149L (en) 1984-07-27
DK38984D0 (da) 1984-01-27
ATE48417T1 (de) 1989-12-15
PL142340B1 (en) 1987-10-31
PT77993A (fr) 1984-02-01
FR2540113A1 (fr) 1984-08-03
MA20018A1 (fr) 1984-10-01
PH21162A (en) 1987-08-05
ES8500243A1 (es) 1984-10-01
AU652118B2 (en) 1994-08-18
AU2372984A (en) 1984-08-02
US4721711A (en) 1988-01-26
FI78691B (fi) 1989-05-31
IL70756A (en) 1987-03-31
FI840323A0 (fi) 1984-01-26
DK162985B (da) 1992-01-06
DD220026A5 (de) 1985-03-20
DE3480653D1 (de) 1990-01-11
ES529081A0 (es) 1984-10-01
PL245931A1 (en) 1985-07-16
EP0117779A1 (fr) 1984-09-05
SG93690G (en) 1991-01-18
OA07644A (fr) 1985-05-23
DK38984A (da) 1984-07-28
PT77993B (fr) 1986-04-10
KR910000638B1 (ko) 1991-01-31
JPS59141564A (ja) 1984-08-14
IE57054B1 (en) 1992-04-08
CA1238637A (en) 1988-06-28
FR2540113B1 (is) 1985-05-17
ZA84502B (en) 1984-09-26

Similar Documents

Publication Publication Date Title
NO840313L (no) Fremgangsmaate for fremstilling av aminosubstituerte pyridazinderivater.
NO164242C (no) Fremgangsmaate for fremstilling av pyrido-imidazo-rifamycin-derivater.
NO160362C (no) Fremgangsmaate for fremstilling av tert.- butylaminoetoksyetanol.
NO851466L (no) Fremgangsmaate for fremstilling av 9a-aza-9a-homoery-tromycin-derivater.
NO872831L (no) FremgangsmŸte for fremstilling av nitrofuranderivater.
NO822510L (no) Fremgangsmaate til fremstilling av pyridazinderivater
NO841657L (no) Fremgangsmaate for fremstilling av ergolinderivater.
NO158136C (no) Fremgangsmaate til fremstilling av tiadiazolderivater.
FI852443A0 (fi) Anordning foer framstaellning av en roerformig behaollarhylsa.
NO158871C (no) Analogifremgangsmaate for fremstilling av pyridazinderivater.
NO157860C (no) Framgangsmaate for framstilling av alkoholer.
NO820980L (no) Fremgangsmaate for fremstilling av imidazo-pyrimidin-derivater
NO166038C (no) Fremgangsmaate til fremstilling av carbapenemderivater.
NO841965L (no) Fremgangsmaate for fremstilling av 1,8-dihydroksy-10-acyl-9-antron-derivater
NO165107C (no) Fremgangsmaate for fremstilling av pyrido-imidazo-rifamycin-derivater.
NO885435L (no) Fremgangsmaate for fremstilling av benzotiazepinderivater.
NO845038L (no) Fremgangsmaate for fremstilling av 4,5,6,7-tetrahydrotiazolo(5,4-c)pyridin-derivater
NO170928C (no) Fremgangsmaate for fremstilling av pyrimidintrionderivater
DK389484A (da) Fremgangsmaade til fremstilling af 2,3-dihydrobenzopyranonderivater
NO912049D0 (no) Fremgangsmaate for fremstilling av aminosubstituerte pyridazinderivater.
MX157611A (es) Procedimiento para preparar derivados de-3-azabiciclo(3.3.1)nonano
NO844466L (no) Fremgangsmaate for fremstilling av pyrimidoisokinolin-derivater
NO841485L (no) Fremgangsmaate for fremstilling av substituerte difenylazometinderivater
NO820979L (no) Fremgangsmaate for fremstilling av pyridinderivater
NO883398L (no) Fremgangsmaate for fremstilling av benzoksazin-derivater.